GlobeNewswire Inc.··NaSionna Therapeutics to Present CF Pipeline at RBC Capital Markets Healthcare Conference
Sionna Therapeutics will present its cystic fibrosis pipeline at RBC Capital Markets Healthcare Conference on May 20, 2026, showcasing NBD1 stabilizer candidates targeting F508del mutation.
SIONcystic fibrosisclinical-stage biopharmaceutical